文献速递慢阻肺

中国人群COPD多维诊断方法的临床验证

Clinical Validation of a Multidimensional Diagnostic Approach for COPD in Chinese Individuals.
PubMed 文献 · Chest · 2025-10-10

基于3年前瞻性多中心社区队列,在中国人群及从不吸烟者中验证COPD多维诊断法。结果显示该法可排除气流阻塞但预后良好者,并识别无气流阻塞但急性加重风险较高者。

要点

  • 多维诊断法可排除气流阻塞但呼吸道预后良好者。
  • 多维诊断法可识别无气流阻塞但急性加重风险较高者。
  • 在从不吸烟者中亦得到相似结果。

核心结论

  • 多维诊断法可排除气流阻塞但呼吸道预后良好者,并识别无气流阻塞但急性加重风险较高者。

研究设计与样本

  • 3年前瞻性多中心社区队列研究,分析中国人群数据,并进行从不吸烟者亚组分析。

主要发现

  • 无气流阻塞者中4.8%(55/1140)符合多维诊断标准。
  • 有气流阻塞者中5.8%(53/915)不符合多维诊断标准。
  • 被多维诊断法排除的气流阻塞者,其急性加重风险和肺功能年下降率与两种标准均判为正常者相似。
  • 无气流阻塞但被重新分类为COPD者,急性加重风险高于两种标准均判为正常者。
  • 在从不吸烟者中发现相似结果。

关键数值与推荐

  • 原COPD诊断标准为支气管舒张后FEV1/FVC < 0.70。
  • 多维诊断法主要标准为支气管舒张后FEV1/FVC < 0.70。
  • 多维诊断法次要标准包括肺气肿、支气管壁增厚、呼吸困难、生活质量差和慢性支气管炎。
  • 主要诊断分类需满足主要标准及至少1项次要标准;次要诊断分类需满足至少3项次要标准。

临床怎么用

  • 在中国人群及从不吸烟者中,可应用多维诊断法排除气流阻塞但预后良好者。
  • 多维诊断法有助于识别无气流阻塞但急性加重风险较高的COPD患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although spirometry is used to diagnose COPD, a new multidimensional diagnostic schema has recently been proposed to diagnose this disease. However, evidence in Chinese individuals and those who never smoked is limited. RESEARCH QUESTION: Is the new multidimensional diagnostic method for COPD practical in the Chinese population and individuals who never smoked? STUDY DESIGN AND METHODS: We analyzed data from a 3-year, prospective, multicenter, community-based cohort study. The previous diagnostic criterion for COPD was postbronchodilator FEV1/FVC < 0.70. The new multidimensional diagnostic schema includes the major diagnostic category (presence of the major criterion and at least 1 of 5 minor criteria) and the minor diagnostic category (presence of least 3 of 5 minor criteria). The main criterion is postbronchodilator FEV1/FVC < 0.70. The minor criteria include emphysema, bronchial wall thickening, dyspnea, poor quality of life, and chronic bronchitis. A subgroup analysis was conducted among individuals who never smoked. RESULTS: Among participants without airflow obstruction, 4.8% (55 of 1,140) met the multidimensional diagnostic criteria; 5.8% (53 of 915) of participants with airflow obstruction did not meet these criteria. Participants with airflow obstruction who were excluded using the multidimensional diagnostic schema for COPD had a risk of exacerbations and annual decline in lung function similar to that in participants diagnosed as normal using both criteria. Participants without airflow obstruction reclassified as having COPD had a higher risk of exacerbations compared with those diagnosed as normal using both criteria. Similar results were found in individuals who never smoked. INTERPRETATION: Our results show that the new multidimensional diagnostic schema for COPD can exclude individuals with airflow obstruction who have a favorable respiratory prognosis and identify those without airflow obstruction who are at higher risk for exacerbations in Chinese individuals and those who never smoked.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Wu, Huang, Zhou, et al. Clinical Validation of a Multidimensional Diagnostic Approach for COPD in Chinese Individuals. Chest. 2025. PMID: 41077384. doi:10.1016/j.chest.2025.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。